In fact, several leukemia and lymphoma disorders have a TET2 that is mutated at notably high frequencies (chronic myelomonocytic leukemia: 35–50%; AITL: 50–80%; PTCL-NOS: 40–50%) [32–37]. This evidence concerns the gene TET2 and chronic myelomonocytic leukemia.